Matches in SemOpenAlex for { <https://semopenalex.org/work/W1603984609> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W1603984609 abstract "OBJECTIVE: Multiple sclerosis is an autoimmune disorder of the CNS that is difficult to diagnose. The goal of this study is to validate a novel diagnostic assay to improve the early, accurate diagnosis of MS. BACKGROUND: The MSPrecise technology was developed based on research into novel patterns of B cell mutations in patients with MS. The study is ongoing, but has enrolled more than 80% of its cohort and preliminary data is available. DESIGN/METHODS: Cerebrospinal fluid (CSF) was collected from human subjects under a IRB-approved protocol. Each subject’s clinical data is evaluated by an adjudication Committee consisting of three practicing MS experts. CSF-derived cells were collected by centrifugation and stored frozen until use. Rearranged Ig heavy chain (IGH) V4(D)J gene segments were amplified from genomic DNA using a two-step PCR protocol based on the 4-primer Amplicon Tagging system (Fluidigm). Amplified and barcoded IGH-V4(D)J PCR amplicons were gel purified and used for Next Generation DNA Sequencing (NGS) using the 454 GS FLX+ Sequencing system and Titanium chemistry (Roche). Barcode sequences were used to identify sequence reads derived from each patient sample. MS Precise scores were then calculated using the remaining unique sequences according to the method of Cameron et al ( J Neuroimmunol . 2009 213:123-130). The MS Precise scores are used to classify patients using a cutoff of 6.8. RESULTS: More than 200 patients have been enrolled to date in the MS Precise Clinical Validation study. This study is ongoing and we project that more than 250 subjects will be enrolled in this by the end of 2013. Approximately 150 subjects have been adjudicated to date with 30% of the subjects receiving a unanimous (3 out of 3) consensus diagnosis of either RRMS or other neurological disease. The performance of MS Precise, based on current data, is 80% sensitive and 83% specific. CONCLUSIONS: MSPrecise represents a novel, biologically important diagnostic test for multiple sclerosis. Study Supported by: DioGenix Disclosure: Dr. Monsonhas received personal compensation from Genentech, Inc. and Medimmune. Dr. Monson has received research support from DioGenix, Inc. Dr. Eastman has received personal compensation for activities with Gene Logic, Inc., Versant Ventures, Calerome, Inc., Pain Therapeutics Inc., and Ritchie Capital Management. Dr. Bigwood has received personal compensation for activities with DioGenix, Inc. Dr. Levin has nothing to disclose. Dr. Rounds has nothing to disclose. Dr. Cowell has nothing to disclose. Dr. Greenberg has received personal compensation for activities with Chugai, GlaxoSmithKline, Inc., Sanofi-Aventis, Diogenix, Biogen Idec, Amplimmune, Acorda, and MSAA. Dr. Greenberg has received personal compensation in an editorial capacity for JAMA Neurology. Dr. Greenberg holds stock and/or stock options in DioGenix, Inc, which sponsored research in which Dr. Greenberg was involved as an investigator. Dr. Greenberg has received research support from Guthy-Jackson Charitable Foundation, Accelerated Cure Project, and Biogen Idec." @default.
- W1603984609 created "2016-06-24" @default.
- W1603984609 creator A5000669492 @default.
- W1603984609 creator A5024040294 @default.
- W1603984609 creator A5029755765 @default.
- W1603984609 creator A5043745865 @default.
- W1603984609 creator A5069802145 @default.
- W1603984609 creator A5071134411 @default.
- W1603984609 creator A5090203652 @default.
- W1603984609 date "2014-04-08" @default.
- W1603984609 modified "2023-09-23" @default.
- W1603984609 title "Update on MSPrecise: A Novel Diagnostic Test for Multiple Sclerosis (P4.138)" @default.
- W1603984609 hasPublicationYear "2014" @default.
- W1603984609 type Work @default.
- W1603984609 sameAs 1603984609 @default.
- W1603984609 citedByCount "0" @default.
- W1603984609 crossrefType "journal-article" @default.
- W1603984609 hasAuthorship W1603984609A5000669492 @default.
- W1603984609 hasAuthorship W1603984609A5024040294 @default.
- W1603984609 hasAuthorship W1603984609A5029755765 @default.
- W1603984609 hasAuthorship W1603984609A5043745865 @default.
- W1603984609 hasAuthorship W1603984609A5069802145 @default.
- W1603984609 hasAuthorship W1603984609A5071134411 @default.
- W1603984609 hasAuthorship W1603984609A5090203652 @default.
- W1603984609 hasConcept C104317684 @default.
- W1603984609 hasConcept C178790620 @default.
- W1603984609 hasConcept C185592680 @default.
- W1603984609 hasConcept C203014093 @default.
- W1603984609 hasConcept C2777563447 @default.
- W1603984609 hasConcept C2780640218 @default.
- W1603984609 hasConcept C49105822 @default.
- W1603984609 hasConcept C51679486 @default.
- W1603984609 hasConcept C54355233 @default.
- W1603984609 hasConcept C552990157 @default.
- W1603984609 hasConcept C60644358 @default.
- W1603984609 hasConcept C70721500 @default.
- W1603984609 hasConcept C71924100 @default.
- W1603984609 hasConcept C8185291 @default.
- W1603984609 hasConcept C86803240 @default.
- W1603984609 hasConceptScore W1603984609C104317684 @default.
- W1603984609 hasConceptScore W1603984609C178790620 @default.
- W1603984609 hasConceptScore W1603984609C185592680 @default.
- W1603984609 hasConceptScore W1603984609C203014093 @default.
- W1603984609 hasConceptScore W1603984609C2777563447 @default.
- W1603984609 hasConceptScore W1603984609C2780640218 @default.
- W1603984609 hasConceptScore W1603984609C49105822 @default.
- W1603984609 hasConceptScore W1603984609C51679486 @default.
- W1603984609 hasConceptScore W1603984609C54355233 @default.
- W1603984609 hasConceptScore W1603984609C552990157 @default.
- W1603984609 hasConceptScore W1603984609C60644358 @default.
- W1603984609 hasConceptScore W1603984609C70721500 @default.
- W1603984609 hasConceptScore W1603984609C71924100 @default.
- W1603984609 hasConceptScore W1603984609C8185291 @default.
- W1603984609 hasConceptScore W1603984609C86803240 @default.
- W1603984609 hasOpenAccess W1603984609 @default.
- W1603984609 hasRelatedWork W1697477849 @default.
- W1603984609 hasRelatedWork W1698058263 @default.
- W1603984609 hasRelatedWork W1703601342 @default.
- W1603984609 hasRelatedWork W1763512765 @default.
- W1603984609 hasRelatedWork W1902903809 @default.
- W1603984609 hasRelatedWork W1904259114 @default.
- W1603984609 hasRelatedWork W1970213344 @default.
- W1603984609 hasRelatedWork W1983594448 @default.
- W1603984609 hasRelatedWork W2128674184 @default.
- W1603984609 hasRelatedWork W2245574032 @default.
- W1603984609 hasRelatedWork W2248451042 @default.
- W1603984609 hasRelatedWork W2325689095 @default.
- W1603984609 hasRelatedWork W2780573163 @default.
- W1603984609 hasRelatedWork W2784547111 @default.
- W1603984609 hasRelatedWork W2800863627 @default.
- W1603984609 hasRelatedWork W2894648148 @default.
- W1603984609 hasRelatedWork W2897777236 @default.
- W1603984609 hasRelatedWork W2900639623 @default.
- W1603984609 hasRelatedWork W2975945853 @default.
- W1603984609 hasRelatedWork W1747772125 @default.
- W1603984609 hasVolume "82" @default.
- W1603984609 isParatext "false" @default.
- W1603984609 isRetracted "false" @default.
- W1603984609 magId "1603984609" @default.
- W1603984609 workType "article" @default.